Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34,802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor Transplantation.
Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, Jacobs R, Knight TG, Usmani SZ, Grunwald MR, Ghosh N, Symanowski JT, Shahid Z, Clark PE, He J. Copelan OR, et al. Among authors: he j. Biol Blood Marrow Transplant. 2019 Apr;25(4):785-790. doi: 10.1016/j.bbmt.2018.12.142. Epub 2018 Dec 20. Biol Blood Marrow Transplant. 2019. PMID: 30579967 Free article.
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity.
Grigg CM, Livasy C, He J, Hartman A, Clark PE, Zhu J, Raghavan D, Burgess EF. Grigg CM, et al. Among authors: he j. Hum Pathol. 2021 Jan;107:96-103. doi: 10.1016/j.humpath.2020.10.006. Epub 2020 Oct 26. Hum Pathol. 2021. PMID: 33121981
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
Grunwald MR, Sha W, He J, Sanikommu S, Gerber JM, Ai J, Knight TG, Fasan O, Boseman V, Kaizen W, Chojecki A, Ragon BK, Symanowski J, Avalos B, Copelan E, Ghosh N. Grunwald MR, et al. Among authors: he j. Transplant Cell Ther. 2024 Dec;30(12):1211.e1-1211.e11. doi: 10.1016/j.jtct.2024.09.021. Epub 2024 Sep 26. Transplant Cell Ther. 2024. PMID: 39332808
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation.
Sanikommu SR, Reese ES, He J, Lee C, Ai J, Butler CM, Jacobs R, Hu B, Atrash S, Trivedi J, Bhutani M, Voorhees P, Usmani SZ, Ghosh N, Fasan O, Druhan LJ, Symanowski J, Copelan EA, Avalos BR. Sanikommu SR, et al. Among authors: he j. J Clin Apher. 2021 Aug;36(4):553-562. doi: 10.1002/jca.21892. Epub 2021 Mar 12. J Clin Apher. 2021. PMID: 33710672
Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes.
Koon A, He J, Patel J, Morse A, Boseman V, Hamilton A, Knight T, Shah N, Ragon B, Chojecki A, Ai J, Steuerwald N, Gerber J, Copelan E, Grunwald M, Arnall J. Koon A, et al. Among authors: he j. Pharmacogenomics. 2023 Oct;24(15):821-830. doi: 10.2217/pgs-2023-0093. Epub 2023 Oct 17. Pharmacogenomics. 2023. PMID: 37846549
34,802 results
You have reached the last available page of results. Please see the User Guide for more information.